Inventera Inc
KOSDAQ:0007J0
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
I
|
Inventera Inc
KOSDAQ:0007J0
|
KR |
|
E
|
Empatho Holdings Inc
CNSX:EMPH
|
CA |
|
R
|
Rokit Healthcare Inc
KOSDAQ:376900
|
KR |
|
C
|
Cathay Chemical Works Inc
TWSE:1713
|
TW |
|
S
|
Samcro Hyosung Adilestari PT Tbk
IDX:ACRO
|
ID |
|
C
|
Carclo PLC
F:C1Y
|
UK |
|
Vistra Corp
LSE:0A8O
|
US |
|
Invex Therapeutics Ltd
ASX:IXC
|
AU |
|
G
|
Green PolkaDot Box Inc
OTC:GPDB
|
US |
|
Cresco Labs Inc
OTC:CRLBF
|
US |
|
R
|
Redwood Group Ltd
TPEX:8426
|
KY |
|
Entrecampos Cuatro Socimi SA
MAD:YENT
|
ES |
|
U
|
US Bancorp
XHAM:UB5
|
US |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Inventera Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Inventera
Inventera, Inc. engages in pharmaceutical research and development. The company is headquartered in Seoul, Seoul. The company went IPO on 2026-04-02. The firm principally develops and researches nano magnetic resonance imaging (MRI) contrast agents based on nanostructured drug delivery platform technologies. The firm's MRI contrast agent includes INV-002, INV-001 and INV-003, mainly used for the diagnosis and treatment of musculoskeletal, lymphatic, as well as pancreatobiliary diseases.
- Sede central
- Corea KR
- Fecha de salida a bolsa
- 2 abr., 2026
